Process View
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an organophosphorus stimulus. Organophosphorus is a compound containing phosphorus bound to an organic molecule; several organophosphorus compounds are used as insecticides, and they are highly toxic cholinesterase inhibitors.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "response to organophosphorus"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
CCNE1 | cyclin E1 | 0.806 | ||
ATF3 | activating transcription factor 3 | 0.797 | ||
EGR1 | early growth response 1 | 0.756 | Human Rat | |
JUNB | jun B proto-oncogene | 0.710 | ||
KCNQ1 | potassium voltage-gated channel, KQT-like subfamily, member 1 | 0.710 | ||
FOS | FBJ murine osteosarcoma viral oncogene homolog | 0.705 | Rat | |
AKR1C2 | aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III) | 0.694 | Human | |
AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1; 20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | 0.630 | ||
NR4A1 | nuclear receptor subfamily 4, group A, member 1 | 0.584 | ||
NR4A2 | nuclear receptor subfamily 4, group A, member 2 | 0.579 | ||
FOSB | FBJ murine osteosarcoma viral oncogene homolog B | 0.550 | Rat | |
KCNE1 | potassium voltage-gated channel, Isk-related family, member 1 | 0.499 | ||
C1R | complement component 1, r subcomponent | 0.424 | ||
NR4A3 | nuclear receptor subfamily 4, group A, member 3 | 0.381 | ||
PTPN13 | protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase) | 0.361 | ||
EGR3 | early growth response 3 | 0.353 | Human | |
PRKAR2A | protein kinase, cAMP-dependent, regulatory, type II, alpha | 0.326 | ||
LIN7B | lin-7 homolog B (C. elegans) | 0.305 | ||
IL1R1 | interleukin 1 receptor, type I | 0.250 | ||
SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.248 | Rat | |
AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | 0.213 | Human | |
IER2 | immediate early response 2 | 0.212 | ||
JUN | jun proto-oncogene | 0.186 | Rat | |
NOSTRIN | nitric oxide synthase trafficker | 0.186 | ||
PLAT | plasminogen activator, tissue | 0.184 | Rat | |
ZFP36 | zinc finger protein 36, C3H type, homolog (mouse) | 0.162 | ||
IL6 | interleukin 6 (interferon, beta 2) | 0.158 | ||
EGR2 | early growth response 2 | 0.155 | Human | |
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.146 | ||
RAF1 | v-raf-1 murine leukemia viral oncogene homolog 1 | 0.143 | ||
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.143 | ||
ATF2 | activating transcription factor 2 | 0.139 | ||
HSPA5 | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 0.123 | ||
SPTBN4 | spectrin, beta, non-erythrocytic 4 | 0.123 | ||
PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.117 | ||
GAST | gastrin | 0.112 | ||
PLAU | plasminogen activator, urokinase | 0.111 | ||
MAPK14 | mitogen-activated protein kinase 14 | 0.104 | ||
FGFR1 | fibroblast growth factor receptor 1 | 0.104 | ||
EGFR | epidermal growth factor receptor | 0.104 | ||
NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.103 | ||
PRMT2 | protein arginine methyltransferase 2 | 0.102 | ||
PDIA3 | protein disulfide isomerase family A, member 3 | 0.099 | ||
IGFBP3 | insulin-like growth factor binding protein 3 | 0.095 | Human | |
SOCS3 | suppressor of cytokine signaling 3 | 0.090 | ||
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.088 | ||
PTGS2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) | 0.086 | Rat | |
DRD2 | dopamine receptor D2 | 0.086 | ||
ADAM12 | ADAM metallopeptidase domain 12 | 0.086 | ||
PHYHIPL | phytanoyl-CoA 2-hydroxylase interacting protein-like | 0.086 | ||
NLRC4 | NLR family, CARD domain containing 4 | 0.085 | ||
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | 0.080 | ||
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.080 | ||
SOS1 | son of sevenless homolog 1 (Drosophila) | 0.073 | Human | |
RAP1A | RAP1A, member of RAS oncogene family | 0.071 | ||
CANX | calnexin | 0.071 | ||
PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.069 | ||
CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.068 | Fly | |
CASP4 | caspase 4, apoptosis-related cysteine peptidase | 0.067 | ||
AXL | AXL receptor tyrosine kinase | 0.062 | ||
PPARGC1A | peroxisome proliferator-activated receptor gamma, coactivator 1 alpha | 0.061 | ||
KSR1 | kinase suppressor of ras 1 | 0.058 | ||
IL1RAP | interleukin 1 receptor accessory protein | 0.057 | ||
PDIA6 | protein disulfide isomerase family A, member 6 | 0.056 | ||
BTG2 | BTG family, member 2 | 0.056 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.055 | ||
DUSP6 | dual specificity phosphatase 6 | 0.055 | ||
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.054 | ||
AQP7 | aquaporin 7 | 0.052 | Human | |
COL1A2 | collagen, type I, alpha 2 | 0.051 | ||
EFEMP2 | EGF containing fibulin-like extracellular matrix protein 2 | 0.050 | ||
MDM2 | Mdm2 p53 binding protein homolog (mouse) | 0.048 | ||
DNM1 | dynamin 1 | 0.048 | ||
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.048 | ||
SKP2 | S-phase kinase-associated protein 2 (p45) | 0.048 | ||
CYR61 | cysteine-rich, angiogenic inducer, 61 | 0.046 | ||
INO80B | INO80 complex subunit B | 0.045 | ||
COL1A1 | collagen, type I, alpha 1 | 0.045 | Rat | |
CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.044 | Fly | |
PROX1 | prospero homeobox 1 | 0.043 | ||
NR0B2 | nuclear receptor subfamily 0, group B, member 2 | 0.043 | ||
PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.042 | ||
RYR2 | ryanodine receptor 2 (cardiac) | 0.042 | ||
KCNJ5 | potassium inwardly-rectifying channel, subfamily J, member 5 | 0.041 | Human | |
MSH6 | mutS homolog 6 (E. coli) | 0.041 | ||
RAPGEF2 | Rap guanine nucleotide exchange factor (GEF) 2 | 0.041 | ||
IGF2 | insulin-like growth factor 2 (somatomedin A) | 0.040 | ||
IL6ST | interleukin 6 signal transducer (gp130, oncostatin M receptor) | 0.040 | ||
TRPC3 | transient receptor potential cation channel, subfamily C, member 3 | 0.040 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.040 | ||
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.039 | ||
ATP8 | ATP synthase F0 subunit 8 | 0.038 | ||
THBS1 | thrombospondin 1 | 0.038 | ||
APOC3 | apolipoprotein C-III | 0.038 | ||
ANGPT1 | angiopoietin 1 | 0.037 | ||
GAB2 | GRB2-associated binding protein 2 | 0.037 | ||
USP2 | ubiquitin specific peptidase 2 | 0.037 | ||
IGF1 | insulin-like growth factor 1 (somatomedin C) | 0.037 | ||
RUNDC3A | RUN domain containing 3A | 0.037 | ||
RFC1 | replication factor C (activator 1) 1, 145kDa | 0.037 | ||
ETS2 | v-ets erythroblastosis virus E26 oncogene homolog 2 (avian) | 0.037 | ||
CXCL3 | chemokine (C-X-C motif) ligand 3 | 0.036 | ||
MAP2 | microtubule-associated protein 2 | 0.036 | ||
LIF | leukemia inhibitory factor (cholinergic differentiation factor) | 0.035 | ||
PRKCE | protein kinase C, epsilon | 0.035 | ||
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.035 | ||
PCGF2 | polycomb group ring finger 2 | 0.034 | ||
PDLIM7 | PDZ and LIM domain 7 (enigma) | 0.033 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.033 | ||
CXCL2 | chemokine (C-X-C motif) ligand 2 | 0.032 | ||
PLCG1 | phospholipase C, gamma 1 | 0.031 | ||
RB1 | retinoblastoma 1 | 0.031 | ||
MAGI2 | membrane associated guanylate kinase, WW and PDZ domain containing 2 | 0.031 | ||
RFC2 | replication factor C (activator 1) 2, 40kDa | 0.031 | ||
KLF4 | Kruppel-like factor 4 (gut) | 0.031 | ||
ORM1 | orosomucoid 1 | 0.031 | ||
TIMP3 | TIMP metallopeptidase inhibitor 3 | 0.031 | ||
VTN | vitronectin | 0.031 | ||
APCS | amyloid P component, serum | 0.031 | ||
BBS1 | Bardet-Biedl syndrome 1 | 0.030 | ||
UBQLN4 | ubiquilin 4 | 0.030 | ||
IL1B | interleukin 1, beta | 0.030 | Mouse | |
PTRF | polymerase I and transcript release factor | 0.030 | ||
PDZK1 | PDZ domain containing 1 | 0.030 | ||
ABCC9 | ATP-binding cassette, sub-family C (CFTR/MRP), member 9 | 0.030 | ||
RHOB | ras homolog gene family, member B | 0.029 | ||
CEBPD | CCAAT/enhancer binding protein (C/EBP), delta | 0.029 | ||
HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.028 | ||
ACP5 | acid phosphatase 5, tartrate resistant | 0.028 | ||
WNT2 | wingless-type MMTV integration site family member 2 | 0.028 | ||
PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.028 | ||
JAK1 | Janus kinase 1 | 0.027 | ||
SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.027 | ||
IGFBP4 | insulin-like growth factor binding protein 4 | 0.027 | Human | |
RIPK2 | receptor-interacting serine-threonine kinase 2 | 0.026 | ||
PYCARD | PYD and CARD domain containing | 0.026 | ||
TAOK1 | TAO kinase 1 | 0.026 | ||
PKD2 | polycystic kidney disease 2 (autosomal dominant) | 0.026 | ||
TFDP1 | transcription factor Dp-1 | 0.026 | ||
TSC22D3 | TSC22 domain family, member 3 | 0.026 | ||
SREBF2 | sterol regulatory element binding transcription factor 2 | 0.026 | ||
IL1RN | interleukin 1 receptor antagonist | 0.026 | ||
CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.026 | Fly | |
PHLDA1 | pleckstrin homology-like domain, family A, member 1 | 0.026 | ||
BHMT | betaine--homocysteine S-methyltransferase | 0.026 | ||
CDC37 | cell division cycle 37 homolog (S. cerevisiae) | 0.025 | ||
DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.025 | ||
SLC9A3R2 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 2 | 0.025 | ||
CHRNA4 | cholinergic receptor, nicotinic, alpha 4 | 0.025 | ||
NFKBIZ | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta | 0.025 | ||
IGFBP5 | insulin-like growth factor binding protein 5 | 0.024 | ||
LGALS4 | lectin, galactoside-binding, soluble, 4 | 0.024 | ||
SSR1 | signal sequence receptor, alpha | 0.024 | ||
TGM2 | transglutaminase 2 (C polypeptide, protein-glutamine-gamma-glutamyltransferase) | 0.024 | ||
CXCL1 | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 0.024 | ||
DCN | decorin | 0.024 | ||
BCL2L1 | BCL2-like 1 | 0.024 | ||
SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 | 0.024 | ||
CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.024 | ||
HSPG2 | heparan sulfate proteoglycan 2 | 0.023 | ||
CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.023 | ||
ADRB2 | adrenergic, beta-2-, receptor, surface | 0.023 | ||
IL8 | interleukin 8 | 0.023 | ||
TPPP | tubulin polymerization promoting protein | 0.023 | ||
OMP | olfactory marker protein | 0.023 | ||
NTSR2 | neurotensin receptor 2 | 0.023 | ||
PRODH2 | proline dehydrogenase (oxidase) 2 | 0.022 | ||
EGR4 | early growth response 4 | 0.022 | Human | |
HCRT | hypocretin (orexin) neuropeptide precursor | 0.022 | ||
ANGPTL4 | angiopoietin-like 4 | 0.022 | ||
PDE4B | phosphodiesterase 4B, cAMP-specific | 0.022 | Human | |
KLF6 | Kruppel-like factor 6 | 0.022 | ||
KCTD17 | potassium channel tetramerisation domain containing 17 | 0.022 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.022 | ||
SCNN1G | sodium channel, nonvoltage-gated 1, gamma | 0.022 | ||
RFC4 | replication factor C (activator 1) 4, 37kDa | 0.022 | ||
TRIB1 | tribbles homolog 1 (Drosophila) | 0.022 | ||
FKBP4 | FK506 binding protein 4, 59kDa | 0.022 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.022 | ||
PTGER3 | prostaglandin E receptor 3 (subtype EP3) | 0.022 | ||
UQCRB | ubiquinol-cytochrome c reductase binding protein | 0.022 | ||
KCNJ10 | potassium inwardly-rectifying channel, subfamily J, member 10 | 0.022 | Human | |
FGB | fibrinogen beta chain | 0.022 | ||
JUND | jun D proto-oncogene | 0.021 | ||
ADRBK1 | adrenergic, beta, receptor kinase 1 | 0.021 | ||
RAMP3 | receptor (G protein-coupled) activity modifying protein 3 | 0.021 | ||
ADRB1 | adrenergic, beta-1-, receptor | 0.021 | ||
PTPRA | protein tyrosine phosphatase, receptor type, A | 0.021 | ||
CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.021 | Fly | |
DUSP2 | dual specificity phosphatase 2 | 0.021 | ||
OSMR | oncostatin M receptor | 0.021 | ||
C3 | complement component 3 | 0.021 | ||
ARAF | v-raf murine sarcoma 3611 viral oncogene homolog | 0.021 | ||
HCN1 | hyperpolarization activated cyclic nucleotide-gated potassium channel 1 | 0.021 | ||
DAO | D-amino-acid oxidase | 0.021 | ||
SNTA1 | syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component) | 0.021 | ||
ADAMTSL4 | ADAMTS-like 4 | 0.021 | ||
MUC1 | mucin 1, cell surface associated | 0.021 | ||
GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0.021 | ||
CSRNP1 | cysteine-serine-rich nuclear protein 1 | 0.021 | ||
PKN2 | protein kinase N2 | 0.020 | ||
COL4A3 | collagen, type IV, alpha 3 (Goodpasture antigen) | 0.020 | ||
SUV39H2 | suppressor of variegation 3-9 homolog 2 (Drosophila) | 0.020 | ||
SLC2A2 | solute carrier family 2 (facilitated glucose transporter), member 2 | 0.020 | ||
KLF10 | Kruppel-like factor 10 | 0.020 | ||
TFPI2 | tissue factor pathway inhibitor 2 | 0.020 | ||
CDK6 | cyclin-dependent kinase 6 | 0.020 | ||
GCKR | glucokinase (hexokinase 4) regulator | 0.020 | ||
OXT | oxytocin, prepropeptide | 0.020 | Rat | |
SIK1 | salt-inducible kinase 1 | 0.020 | ||
NCOA7 | nuclear receptor coactivator 7 | 0.020 | ||
PPP5C | protein phosphatase 5, catalytic subunit | 0.020 | ||
S100A2 | S100 calcium binding protein A2 | 0.020 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.020 | ||
MESDC2 | mesoderm development candidate 2 | 0.020 | ||
CITED1 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1 | 0.020 | Mouse | |
GCGR | glucagon receptor | 0.020 | ||
MAPK3 | mitogen-activated protein kinase 3 | 0.020 | ||
S100A1 | S100 calcium binding protein A1 | 0.020 | ||
C6 | complement component 6 | 0.020 | ||
PTN | pleiotrophin | 0.020 | ||
NAB2 | NGFI-A binding protein 2 (EGR1 binding protein 2) | 0.020 | ||
TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.020 | ||
TRPC6 | transient receptor potential cation channel, subfamily C, member 6 | 0.020 | Human | |
BLNK | B-cell linker | 0.019 | ||
CDKN1B | cyclin-dependent kinase inhibitor 1B (p27, Kip1) | 0.019 | ||
FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.019 | ||
CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.019 | ||
ATXN1 | ataxin 1 | 0.019 | ||
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.019 | ||
TNFRSF12A | tumor necrosis factor receptor superfamily, member 12A | 0.019 | ||
FOXO1 | forkhead box O1 | 0.019 | ||
NCOA2 | nuclear receptor coactivator 2 | 0.019 | ||
GFAP | glial fibrillary acidic protein | 0.019 | ||
PIK3AP1 | phosphoinositide-3-kinase adaptor protein 1 | 0.019 | ||
HSD11B1 | hydroxysteroid (11-beta) dehydrogenase 1 | 0.019 | ||
CRHBP | corticotropin releasing hormone binding protein | 0.019 | ||
VAV3 | vav 3 guanine nucleotide exchange factor | 0.019 | ||
NR1I3 | nuclear receptor subfamily 1, group I, member 3 | 0.019 | ||
PDE4D | phosphodiesterase 4D, cAMP-specific | 0.019 | ||
CACNA1G | calcium channel, voltage-dependent, T type, alpha 1G subunit | 0.019 | ||
LIMK1 | LIM domain kinase 1 | 0.018 | ||
SLC13A2 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | 0.018 | ||
INHA | inhibin, alpha | 0.018 | ||
ESRRG | estrogen-related receptor gamma | 0.018 | ||
CCND1 | cyclin D1 | 0.018 | ||
SGK2 | serum/glucocorticoid regulated kinase 2 | 0.018 | ||
GEM | GTP binding protein overexpressed in skeletal muscle | 0.018 | ||
KCNJ3 | potassium inwardly-rectifying channel, subfamily J, member 3 | 0.018 | Human | |
IGFBP7 | insulin-like growth factor binding protein 7 | 0.018 | ||
TIE1 | tyrosine kinase with immunoglobulin-like and EGF-like domains 1 | 0.018 | ||
AMBP | alpha-1-microglobulin/bikunin precursor | 0.018 | ||
GLRA1 | glycine receptor, alpha 1 | 0.018 | ||
DPYS | dihydropyrimidinase | 0.018 | ||
SUV39H1 | suppressor of variegation 3-9 homolog 1 (Drosophila) | 0.018 | ||
KCNJ16 | potassium inwardly-rectifying channel, subfamily J, member 16 | 0.018 | Human | |
TPX2 | TPX2, microtubule-associated, homolog (Xenopus laevis) | 0.018 | ||
RGS1 | regulator of G-protein signaling 1 | 0.017 | ||
AVPR1B | arginine vasopressin receptor 1B | 0.017 | ||
SNAI1 | snail homolog 1 (Drosophila) | 0.017 | ||
PKLR | pyruvate kinase, liver and RBC | 0.017 | Rat | |
GAB1 | GRB2-associated binding protein 1 | 0.017 | ||
GK | glycerol kinase | 0.017 | ||
DVL3 | dishevelled, dsh homolog 3 (Drosophila) | 0.017 | ||
XPNPEP2 | X-prolyl aminopeptidase (aminopeptidase P) 2, membrane-bound | 0.017 | ||
KCNJ9 | potassium inwardly-rectifying channel, subfamily J, member 9 | 0.017 | Human | |
DDR2 | discoidin domain receptor tyrosine kinase 2 | 0.017 | ||
CLEC4G | C-type lectin domain family 4, member G | 0.017 | ||
STAT5A | signal transducer and activator of transcription 5A | 0.017 | ||
SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.017 | ||
TM4SF5 | transmembrane 4 L six family member 5 | 0.017 | ||
TRPC4 | transient receptor potential cation channel, subfamily C, member 4 | 0.017 | Human | |
MED15 | mediator complex subunit 15 | 0.017 | ||
MUSK | muscle, skeletal, receptor tyrosine kinase | 0.017 | ||
SLC10A1 | solute carrier family 10 (sodium/bile acid cotransporter family), member 1 | 0.017 | ||
SLCO2A1 | solute carrier organic anion transporter family, member 2A1 | 0.017 | ||
CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.017 | ||
C8A | complement component 8, alpha polypeptide | 0.017 | ||
AADAC | arylacetamide deacetylase (esterase) | 0.017 | ||
CD83 | CD83 molecule | 0.017 | ||
EIF2AK3 | eukaryotic translation initiation factor 2-alpha kinase 3 | 0.017 | ||
TPM2 | tropomyosin 2 (beta) | 0.017 | ||
KRT8 | keratin 8 | 0.017 | ||
DUSP5 | dual specificity phosphatase 5 | 0.017 | ||
ADRA1D | adrenergic, alpha-1D-, receptor | 0.017 | ||
PPP1R1A | protein phosphatase 1, regulatory (inhibitor) subunit 1A | 0.017 | ||
TRAM1 | translocation associated membrane protein 1 | 0.017 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.017 | ||
COL4A1 | collagen, type IV, alpha 1 | 0.017 | ||
MASP2 | mannan-binding lectin serine peptidase 2 | 0.016 | ||
GABRD | gamma-aminobutyric acid (GABA) A receptor, delta | 0.016 | ||
SLC6A2 | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 0.016 | ||
MMP2 | matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) | 0.016 | ||
COL3A1 | collagen, type III, alpha 1 | 0.016 | ||
ZDHHC17 | zinc finger, DHHC-type containing 17 | 0.016 | ||
A2M | alpha-2-macroglobulin | 0.016 | ||
ADH6 | alcohol dehydrogenase 6 (class V) | 0.016 | ||
ESR2 | estrogen receptor 2 (ER beta) | 0.016 | ||
SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.016 | ||
IER3 | immediate early response 3 | 0.016 | ||
DCT | dopachrome tautomerase (dopachrome delta-isomerase, tyrosine-related protein 2) | 0.016 | ||
TRIM11 | tripartite motif containing 11 | 0.016 | ||
PPY | pancreatic polypeptide | 0.016 | ||
ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 0.016 | ||
MAG | myelin associated glycoprotein | 0.016 | ||
HCN4 | hyperpolarization activated cyclic nucleotide-gated potassium channel 4 | 0.016 | ||
SGK1 | serum/glucocorticoid regulated kinase 1 | 0.016 | ||
CLU | clusterin | 0.016 | ||
G6PC | glucose-6-phosphatase, catalytic subunit | 0.016 | ||
S100A4 | S100 calcium binding protein A4 | 0.016 | ||
ACACA | acetyl-CoA carboxylase alpha | 0.016 | ||
GNB3 | guanine nucleotide binding protein (G protein), beta polypeptide 3 | 0.016 | ||
RGS2 | regulator of G-protein signaling 2, 24kDa | 0.016 | ||
CFI | complement factor I | 0.016 | ||
PFKFB1 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 | 0.016 | Rat | |
PTGES | prostaglandin E synthase | 0.016 | ||
TF | transferrin | 0.016 | Rat | |
KCNQ2 | potassium voltage-gated channel, KQT-like subfamily, member 2 | 0.016 | Human | |
PICK1 | protein interacting with PRKCA 1 | 0.016 | ||
MLLT6 | myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6 | 0.016 | ||
GUCA2B | guanylate cyclase activator 2B (uroguanylin) | 0.016 | ||
DAG1 | dystroglycan 1 (dystrophin-associated glycoprotein 1) | 0.016 | ||
BCR | breakpoint cluster region | 0.016 | ||
SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.016 | ||
CCL20 | chemokine (C-C motif) ligand 20 | 0.015 | ||
PCDH17 | protocadherin 17 | 0.015 | ||
AR | androgen receptor | 0.015 | ||
YBX1 | Y box binding protein 1 | 0.015 | ||
CITED2 | Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 | 0.015 | ||
CLCNKB | chloride channel Kb | 0.015 | ||
MGST3 | microsomal glutathione S-transferase 3 | 0.015 | ||
GCK | glucokinase (hexokinase 4) | 0.015 | ||
TAT | tyrosine aminotransferase | 0.015 | ||
CHRNB2 | cholinergic receptor, nicotinic, beta 2 (neuronal) | 0.015 | ||
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | 0.015 | ||
PHKG1 | phosphorylase kinase, gamma 1 (muscle) | 0.015 | ||
PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.015 | ||
SOS2 | son of sevenless homolog 2 (Drosophila) | 0.015 | Human | |
TFPI | tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) | 0.015 | ||
P2RX6 | purinergic receptor P2X, ligand-gated ion channel, 6 | 0.015 | Human | |
DUSP1 | dual specificity phosphatase 1 | 0.015 | Rat | |
PRKCD | protein kinase C, delta | 0.015 | ||
PHF19 | PHD finger protein 19 | 0.015 | ||
GP2 | glycoprotein 2 (zymogen granule membrane) | 0.015 | ||
PTPRE | protein tyrosine phosphatase, receptor type, E | 0.015 | ||
PPARG | peroxisome proliferator-activated receptor gamma | 0.015 | ||
CUBN | cubilin (intrinsic factor-cobalamin receptor) | 0.015 | ||
PIGR | polymeric immunoglobulin receptor | 0.015 | ||
CCL2 | chemokine (C-C motif) ligand 2 | 0.015 | ||
DNAJC1 | DnaJ (Hsp40) homolog, subfamily C, member 1 | 0.015 | ||
CACNA1H | calcium channel, voltage-dependent, T type, alpha 1H subunit | 0.015 | ||
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.015 | ||
SLC2A4 | solute carrier family 2 (facilitated glucose transporter), member 4 | 0.015 | ||
TRPC5 | transient receptor potential cation channel, subfamily C, member 5 | 0.015 | Human | |
RHO | rhodopsin | 0.015 | ||
HRH3 | histamine receptor H3 | 0.015 | ||
ART1 | ADP-ribosyltransferase 1 | 0.015 | ||
CAMK2B | calcium/calmodulin-dependent protein kinase II beta | 0.015 | ||
SH3BP2 | SH3-domain binding protein 2 | 0.015 | ||
ARNTL | aryl hydrocarbon receptor nuclear translocator-like | 0.015 | ||
F9 | coagulation factor IX | 0.015 | ||
CIDEC | cell death-inducing DFFA-like effector c | 0.015 | ||
THPO | thrombopoietin | 0.015 | ||
KLF5 | Kruppel-like factor 5 (intestinal) | 0.015 | ||
RANBP3 | RAN binding protein 3 | 0.015 | ||
CALCA | calcitonin-related polypeptide alpha | 0.015 | ||
NPY2R | neuropeptide Y receptor Y2 | 0.015 | ||
HSPA8 | heat shock 70kDa protein 8 | 0.014 | ||
EDN3 | endothelin 3 | 0.014 | ||
FAM65B | family with sequence similarity 65, member B | 0.014 | ||
ASB4 | ankyrin repeat and SOCS box containing 4 | 0.014 | ||
SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.014 | ||
LAMC3 | laminin, gamma 3 | 0.014 | ||
IL10 | interleukin 10 | 0.014 | ||
IGFBP1 | insulin-like growth factor binding protein 1 | 0.014 | Human | |
IGFBP2 | insulin-like growth factor binding protein 2, 36kDa | 0.014 | Human | |
SCGB1A1 | secretoglobin, family 1A, member 1 (uteroglobin) | 0.014 | ||
GPD1 | glycerol-3-phosphate dehydrogenase 1 (soluble) | 0.014 | Mouse | |
CP | ceruloplasmin (ferroxidase) | 0.014 | ||
KCNC3 | potassium voltage-gated channel, Shaw-related subfamily, member 3 | 0.014 | ||
TUBB6 | tubulin, beta 6 | 0.014 | ||
TFF1 | trefoil factor 1 | 0.014 | ||
MADCAM1 | mucosal vascular addressin cell adhesion molecule 1 | 0.014 | ||
TNFAIP6 | tumor necrosis factor, alpha-induced protein 6 | 0.014 | ||
NDUFB5 | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 5, 16kDa | 0.014 | ||
GOPC | golgi-associated PDZ and coiled-coil motif containing | 0.014 | ||
CLCF1 | cardiotrophin-like cytokine factor 1 | 0.014 | ||
MCCC1 | methylcrotonoyl-CoA carboxylase 1 (alpha) | 0.014 | ||
HSD3B1 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 | 0.014 | Rat | |
VWF | von Willebrand factor | 0.014 | ||
PRKACA | protein kinase, cAMP-dependent, catalytic, alpha | 0.014 | ||
NCOA1 | nuclear receptor coactivator 1 | 0.014 | ||
GLYAT | glycine-N-acyltransferase | 0.014 | ||
ANAPC1 | anaphase promoting complex subunit 1 | 0.014 | ||
MCM3 | minichromosome maintenance complex component 3 | 0.014 | ||
SLC10A2 | solute carrier family 10 (sodium/bile acid cotransporter family), member 2 | 0.014 | ||
PDCD6IP | programmed cell death 6 interacting protein | 0.014 | ||
HBEGF | heparin-binding EGF-like growth factor | 0.014 | ||
CDH22 | cadherin 22, type 2 | 0.014 | ||
NCOA6 | nuclear receptor coactivator 6 | 0.014 | ||
BMP8A | bone morphogenetic protein 8a | 0.014 | ||
SLC1A2 | solute carrier family 1 (glial high affinity glutamate transporter), member 2 | 0.014 | ||
HYAL1 | hyaluronoglucosaminidase 1 | 0.014 | ||
HAAO | 3-hydroxyanthranilate 3,4-dioxygenase | 0.014 | ||
TXNDC11 | thioredoxin domain containing 11 | 0.014 | ||
DNAJB11 | DnaJ (Hsp40) homolog, subfamily B, member 11 | 0.014 | ||
FN1 | fibronectin 1 | 0.014 | ||
GFPT2 | glutamine-fructose-6-phosphate transaminase 2 | 0.014 | ||
SLC6A4 | solute carrier family 6 (neurotransmitter transporter, serotonin), member 4 | 0.014 | ||
PIK3CB | phosphoinositide-3-kinase, catalytic, beta polypeptide | 0.014 | ||
THBD | thrombomodulin | 0.013 | ||
SNCG | synuclein, gamma (breast cancer-specific protein 1) | 0.013 | ||
HTR4 | 5-hydroxytryptamine (serotonin) receptor 4 | 0.013 | ||
OPRK1 | opioid receptor, kappa 1 | 0.013 | ||
DVL1 | dishevelled, dsh homolog 1 (Drosophila) | 0.013 | ||
GRIP1 | glutamate receptor interacting protein 1 | 0.013 | ||
CRYBB3 | crystallin, beta B3 | 0.013 | ||
RAP1GAP | RAP1 GTPase activating protein | 0.013 | ||
RGS16 | regulator of G-protein signaling 16 | 0.013 | ||
C8B | complement component 8, beta polypeptide | 0.013 | ||
GJB1 | gap junction protein, beta 1, 32kDa | 0.013 | ||
TH | tyrosine hydroxylase | 0.013 | ||
SCD | stearoyl-CoA desaturase (delta-9-desaturase) | 0.013 | ||
LIG1 | ligase I, DNA, ATP-dependent | 0.013 | ||
ITPR1 | inositol 1,4,5-trisphosphate receptor, type 1 | 0.013 | Rat | |
LOX | lysyl oxidase | 0.013 | ||
PTHLH | parathyroid hormone-like hormone | 0.013 | ||
RHBDL1 | rhomboid, veinlet-like 1 (Drosophila) | 0.013 | ||
RXRG | retinoid X receptor, gamma | 0.013 | ||
PTOV1 | prostate tumor overexpressed 1 | 0.013 | ||
AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | 0.013 | ||
MAF | v-maf musculoaponeurotic fibrosarcoma oncogene homolog (avian) | 0.013 | ||
GSTA3 | glutathione S-transferase alpha 3 | 0.013 | ||
RASSF5 | Ras association (RalGDS/AF-6) domain family member 5 | 0.013 | ||
CD69 | CD69 molecule | 0.013 | ||
ACHE | acetylcholinesterase | 0.013 | ||
JAK2 | Janus kinase 2 | 0.013 | ||
YWHAH | tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide | 0.013 | ||
ALOX15B | arachidonate 15-lipoxygenase, type B | 0.013 | ||
PITPNM3 | PITPNM family member 3 | 0.013 | ||
GRM3 | glutamate receptor, metabotropic 3 | 0.013 | ||
NUCB1 | nucleobindin 1 | 0.013 | ||
HOXB1 | homeobox B1 | 0.013 | ||
GPX3 | glutathione peroxidase 3 (plasma) | 0.013 | ||
HNF1B | HNF1 homeobox B | 0.013 | ||
PANX2 | pannexin 2 | 0.013 | ||
CSF1 | colony stimulating factor 1 (macrophage) | 0.013 | ||
MAPK8 | mitogen-activated protein kinase 8 | 0.013 | ||
NR1I2 | nuclear receptor subfamily 1, group I, member 2 | 0.013 | ||
GHRHR | growth hormone releasing hormone receptor | 0.013 | ||
DLGAP2 | discs, large (Drosophila) homolog-associated protein 2 | 0.013 | ||
PPP3CA | protein phosphatase 3, catalytic subunit, alpha isozyme | 0.013 | ||
MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.013 | ||
SDS | serine dehydratase | 0.013 | ||
IL1R2 | interleukin 1 receptor, type II | 0.013 | ||
CALU | calumenin | 0.013 | ||
FAIM2 | Fas apoptotic inhibitory molecule 2 | 0.013 | ||
SLC22A7 | solute carrier family 22 (organic anion transporter), member 7 | 0.013 | ||
AKAP13 | A kinase (PRKA) anchor protein 13 | 0.013 | ||
NPPC | natriuretic peptide C | 0.013 | ||
DYRK1A | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 1A | 0.013 | ||
MCM2 | minichromosome maintenance complex component 2 | 0.013 | ||
KCNK13 | potassium channel, subfamily K, member 13 | 0.013 | ||
DLGAP3 | discs, large (Drosophila) homolog-associated protein 3 | 0.013 | ||
PRKCG | protein kinase C, gamma | 0.013 | ||
HHEX | hematopoietically expressed homeobox | 0.013 | ||
SLC28A1 | solute carrier family 28 (sodium-coupled nucleoside transporter), member 1 | 0.013 | ||
PDLIM4 | PDZ and LIM domain 4 | 0.013 | ||
KLF2 | Kruppel-like factor 2 (lung) | 0.013 | ||
GHSR | growth hormone secretagogue receptor | 0.013 | ||
KCNQ3 | potassium voltage-gated channel, KQT-like subfamily, member 3 | 0.013 | Human | |
EMP1 | epithelial membrane protein 1 | 0.013 | ||
SOX1 | SRY (sex determining region Y)-box 1 | 0.013 | ||
SRGN | serglycin | 0.013 | ||
DNAJA1 | DnaJ (Hsp40) homolog, subfamily A, member 1 | 0.013 | ||
VIL1 | villin 1 | 0.013 | ||
SYT9 | synaptotagmin IX | 0.012 | ||
SCN8A | sodium channel, voltage gated, type VIII, alpha subunit | 0.012 | ||
ADCYAP1 | adenylate cyclase activating polypeptide 1 (pituitary) | 0.012 | ||
BCKDHA | branched chain keto acid dehydrogenase E1, alpha polypeptide | 0.012 | ||
MBL2 | mannose-binding lectin (protein C) 2, soluble | 0.012 | ||
MTA2 | metastasis associated 1 family, member 2 | 0.012 | ||
HCN2 | hyperpolarization activated cyclic nucleotide-gated potassium channel 2 | 0.012 | ||
TNR | tenascin R (restrictin, janusin) | 0.012 | ||
KNDC1 | kinase non-catalytic C-lobe domain (KIND) containing 1 | 0.012 | ||
GUCY2C | guanylate cyclase 2C (heat stable enterotoxin receptor) | 0.012 | ||
KCTD15 | potassium channel tetramerisation domain containing 15 | 0.012 | ||
HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.012 | Rat | |
AVPR1A | arginine vasopressin receptor 1A | 0.012 | ||
HTR2A | 5-hydroxytryptamine (serotonin) receptor 2A | 0.012 | ||
PNLIPRP1 | pancreatic lipase-related protein 1 | 0.012 | ||
CH25H | cholesterol 25-hydroxylase | 0.012 | ||
WDR44 | WD repeat domain 44 | 0.012 | ||
CAV2 | caveolin 2 | 0.012 | ||
SEZ6L | seizure related 6 homolog (mouse)-like | 0.012 | ||
PDE1C | phosphodiesterase 1C, calmodulin-dependent 70kDa | 0.012 | Human | |
PAH | phenylalanine hydroxylase | 0.012 | ||
KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.012 | ||
RHOU | ras homolog gene family, member U | 0.012 | ||
SPTB | spectrin, beta, erythrocytic | 0.012 | ||
G0S2 | G0/G1switch 2 | 0.012 | ||
SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.012 | ||
NR5A2 | nuclear receptor subfamily 5, group A, member 2 | 0.012 | ||
S100A5 | S100 calcium binding protein A5 | 0.012 | ||
PDE4A | phosphodiesterase 4A, cAMP-specific | 0.012 | Human | |
CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.012 | ||
HAS1 | hyaluronan synthase 1 | 0.012 | ||
CDK1 | cyclin-dependent kinase 1 | 0.012 | ||
PIK3CA | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 0.012 | ||
TREM1 | triggering receptor expressed on myeloid cells 1 | 0.012 | ||
SLC6A13 | solute carrier family 6 (neurotransmitter transporter, GABA), member 13 | 0.012 | ||
LHCGR | luteinizing hormone/choriogonadotropin receptor | 0.012 | ||
HSD17B3 | hydroxysteroid (17-beta) dehydrogenase 3 | 0.012 | ||
CELF2 | CUGBP, Elav-like family member 2 | 0.012 | ||
CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.012 | ||
MPRIP | myosin phosphatase Rho interacting protein | 0.012 | ||
JDP2 | Jun dimerization protein 2 | 0.012 | ||
NAT8B | N-acetyltransferase 8B (GCN5-related, putative, gene/pseudogene) | 0.012 | ||
GRIK1 | glutamate receptor, ionotropic, kainate 1 | 0.012 | ||
C10orf46 | chromosome 10 open reading frame 46 | 0.012 | ||
PTPRN | protein tyrosine phosphatase, receptor type, N | 0.012 | Rat | |
SLC34A1 | solute carrier family 34 (sodium phosphate), member 1 | 0.012 | ||
CNGA1 | cyclic nucleotide gated channel alpha 1 | 0.012 | ||
PRELP | proline/arginine-rich end leucine-rich repeat protein | 0.012 | ||
KCNJ1 | potassium inwardly-rectifying channel, subfamily J, member 1 | 0.012 | Human | |
PRDM12 | PR domain containing 12 | 0.012 | ||
HSD17B2 | hydroxysteroid (17-beta) dehydrogenase 2 | 0.012 | ||
SERPINA5 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5 | 0.012 | ||
TRPC7 | transient receptor potential cation channel, subfamily C, member 7 | 0.012 | Human | |
CYP2D6 | cytochrome P450, family 2, subfamily D, polypeptide 6 | 0.012 | ||
CCRN4L | CCR4 carbon catabolite repression 4-like (S. cerevisiae) | 0.012 | ||
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.012 | ||
MGP | matrix Gla protein | 0.012 | ||
GPLD1 | glycosylphosphatidylinositol specific phospholipase D1 | 0.012 | ||
PTGER1 | prostaglandin E receptor 1 (subtype EP1), 42kDa | 0.012 | ||
HNF4A | hepatocyte nuclear factor 4, alpha | 0.012 | Rat | |
ADRB3 | adrenergic, beta-3-, receptor | 0.012 | ||
GAD2 | glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa) | 0.012 | ||
CACNA1B | calcium channel, voltage-dependent, N type, alpha 1B subunit | 0.012 | ||
TFRC | transferrin receptor (p90, CD71) | 0.012 | ||
MCHR1 | melanin-concentrating hormone receptor 1 | 0.012 | ||
TAGLN | transgelin | 0.012 | ||
GRM1 | glutamate receptor, metabotropic 1 | 0.012 | ||
COL4A4 | collagen, type IV, alpha 4 | 0.012 | ||
ACAN | aggrecan | 0.012 | ||
COL5A3 | collagen, type V, alpha 3 | 0.012 | ||
GRIA3 | glutamate receptor, ionotrophic, AMPA 3 | 0.012 | ||
ANGPT2 | angiopoietin 2 | 0.012 | ||
TREH | trehalase (brush-border membrane glycoprotein) | 0.012 | ||
CUX1 | cut-like homeobox 1 | 0.012 | ||
APOC4 | apolipoprotein C-IV | 0.012 | ||
NOVA2 | neuro-oncological ventral antigen 2 | 0.012 | ||
VEGFC | vascular endothelial growth factor C | 0.011 | ||
CFB | complement factor B | 0.011 | ||
TBR1 | T-box, brain, 1 | 0.011 | ||
BZW1 | basic leucine zipper and W2 domains 1 | 0.011 | ||
SLC29A1 | solute carrier family 29 (nucleoside transporters), member 1 | 0.011 | ||
SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.011 | ||
RHOJ | ras homolog gene family, member J | 0.011 | ||
NRIP1 | nuclear receptor interacting protein 1 | 0.011 | ||
PITPNM2 | phosphatidylinositol transfer protein, membrane-associated 2 | 0.011 | ||
C8G | complement component 8, gamma polypeptide | 0.011 | ||
RELN | reelin | 0.011 | ||
DNAJB9 | DnaJ (Hsp40) homolog, subfamily B, member 9 | 0.011 | ||
KLHDC3 | kelch domain containing 3 | 0.011 | ||
DRD3 | dopamine receptor D3 | 0.011 | ||
ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.011 | ||
PRLH | prolactin releasing hormone | 0.011 | ||
CYP11A1 | cytochrome P450, family 11, subfamily A, polypeptide 1 | 0.011 | ||
SLC11A1 | solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 | 0.011 | ||
RBP4 | retinol binding protein 4, plasma | 0.011 | ||
ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | 0.011 | ||
ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.011 | ||
SPP1 | secreted phosphoprotein 1 | 0.011 | ||
CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 | 0.011 | ||
PON1 | paraoxonase 1 | 0.011 | ||
GH2 | growth hormone 2 | 0.011 | ||
HRG | histidine-rich glycoprotein | 0.011 | ||
OPRD1 | opioid receptor, delta 1 | 0.011 | ||
DPYSL4 | dihydropyrimidinase-like 4 | 0.011 | ||
PCDH12 | protocadherin 12 | 0.011 | ||
MAPK10 | mitogen-activated protein kinase 10 | 0.011 | ||
GPR183 | G protein-coupled receptor 183 | 0.011 | ||
NPPA | natriuretic peptide A | 0.011 | ||
GAS6 | growth arrest-specific 6 | 0.011 | ||
PPYR1 | pancreatic polypeptide receptor 1 | 0.011 | ||
ARG1 | arginase, liver | 0.011 | ||
GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 0.011 | ||
SIRPA | signal-regulatory protein alpha | 0.011 | ||
GADD45B | growth arrest and DNA-damage-inducible, beta | 0.011 | ||
OTC | ornithine carbamoyltransferase | 0.011 | ||
HTRA1 | HtrA serine peptidase 1 | 0.011 | ||
AQP9 | aquaporin 9 | 0.011 | ||
CXCL12 | chemokine (C-X-C motif) ligand 12 | 0.011 | ||
PLA2G4A | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 0.011 | ||
SCRG1 | stimulator of chondrogenesis 1 | 0.011 | ||
PPP1R15A | protein phosphatase 1, regulatory (inhibitor) subunit 15A | 0.011 | ||
GLTPD1 | glycolipid transfer protein domain containing 1 | 0.011 | ||
COL5A1 | collagen, type V, alpha 1 | 0.011 | ||
NEUROG1 | neurogenin 1 | 0.011 | ||
FAM107A | family with sequence similarity 107, member A | 0.011 | ||
COL6A1 | collagen, type VI, alpha 1 | 0.011 | ||
SLC6A7 | solute carrier family 6 (neurotransmitter transporter, L-proline), member 7 | 0.011 | ||
CD34 | CD34 molecule | 0.011 | ||
LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.011 | ||
NR1H4 | nuclear receptor subfamily 1, group H, member 4 | 0.011 | ||
CCL4 | chemokine (C-C motif) ligand 4 | 0.011 | ||
AQP6 | aquaporin 6, kidney specific | 0.011 | Human | |
SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.011 | Rat | |
GSN | gelsolin | 0.011 | ||
CRHR1 | corticotropin releasing hormone receptor 1 | 0.011 | ||
APOD | apolipoprotein D | 0.011 | ||
CD44 | CD44 molecule (Indian blood group) | 0.011 | ||
SPSB1 | splA/ryanodine receptor domain and SOCS box containing 1 | 0.011 | ||
PGR | progesterone receptor | 0.011 | ||
PDX1 | pancreatic and duodenal homeobox 1 | 0.011 | ||
F2 | coagulation factor II (thrombin) | 0.011 | ||
TLR3 | toll-like receptor 3 | 0.011 | ||
SRY | sex determining region Y | 0.011 | ||
C4BPB | complement component 4 binding protein, beta | 0.011 | ||
PLIN1 | perilipin 1 | 0.011 | ||
TARS | threonyl-tRNA synthetase | 0.011 | ||
STMN4 | stathmin-like 4 | 0.011 | ||
GRIN2D | glutamate receptor, ionotropic, N-methyl D-aspartate 2D | 0.011 | ||
INHBB | inhibin, beta B | 0.011 | ||
NID1 | nidogen 1 | 0.011 | ||
MAP2K1 | mitogen-activated protein kinase kinase 1 | 0.011 | ||
MAPK8IP1 | mitogen-activated protein kinase 8 interacting protein 1 | 0.011 | ||
KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.011 | ||
S100A7 | S100 calcium binding protein A7 | 0.011 | ||
HADH | hydroxyacyl-CoA dehydrogenase | 0.011 | ||
TMEM97 | transmembrane protein 97 | 0.011 | ||
REG1A | regenerating islet-derived 1 alpha | 0.011 | ||
PXN | paxillin | 0.011 | ||
SLC6A1 | solute carrier family 6 (neurotransmitter transporter, GABA), member 1 | 0.011 | ||
FSCN1 | fascin homolog 1, actin-bundling protein (Strongylocentrotus purpuratus) | 0.011 | ||
TRPM1 | transient receptor potential cation channel, subfamily M, member 1 | 0.011 | ||
NBL1 | neuroblastoma, suppression of tumorigenicity 1 | 0.011 | ||
CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.011 | ||
PPAT | phosphoribosyl pyrophosphate amidotransferase | 0.011 | ||
UCP1 | uncoupling protein 1 (mitochondrial, proton carrier) | 0.011 | ||
DNAJC10 | DnaJ (Hsp40) homolog, subfamily C, member 10 | 0.011 | ||
ATP1B2 | ATPase, Na+/K+ transporting, beta 2 polypeptide | 0.011 | ||
APP | amyloid beta (A4) precursor protein | 0.011 | ||
FPR1 | formyl peptide receptor 1 | 0.011 | ||
ELAVL3 | ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C) | 0.011 | ||
SLC5A5 | solute carrier family 5 (sodium iodide symporter), member 5 | 0.011 | ||
MAGI3 | membrane associated guanylate kinase, WW and PDZ domain containing 3 | 0.011 | ||
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | 0.011 | ||
ADRA2B | adrenergic, alpha-2B-, receptor | 0.011 | ||
ANGPT4 | angiopoietin 4 | 0.011 | ||
CXCL14 | chemokine (C-X-C motif) ligand 14 | 0.011 | ||
KIAA1109 | KIAA1109 | 0.011 | ||
SP100 | SP100 nuclear antigen | 0.011 | ||
IL1A | interleukin 1, alpha | 0.011 | ||
GYS2 | glycogen synthase 2 (liver) | 0.011 | ||
GRM2 | glutamate receptor, metabotropic 2 | 0.011 | ||
HSPH1 | heat shock 105kDa/110kDa protein 1 | 0.011 | ||
SLC6A5 | solute carrier family 6 (neurotransmitter transporter, glycine), member 5 | 0.011 | ||
CFH | complement factor H | 0.011 | ||
REPS2 | RALBP1 associated Eps domain containing 2 | 0.011 | ||
BDKRB2 | bradykinin receptor B2 | 0.011 | ||
CCND3 | cyclin D3 | 0.011 | ||
COL9A2 | collagen, type IX, alpha 2 | 0.011 | ||
C9 | complement component 9 | 0.011 | ||
SLC4A1 | solute carrier family 4, anion exchanger, member 1 (erythrocyte membrane protein band 3, Diego blood group) | 0.011 | ||
ITSN2 | intersectin 2 | 0.011 | ||
DUSP4 | dual specificity phosphatase 4 | 0.010 | ||
TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.010 | ||
CPN1 | carboxypeptidase N, polypeptide 1 | 0.010 | ||
KCNH6 | potassium voltage-gated channel, subfamily H (eag-related), member 6 | 0.010 | ||
QKI | quaking homolog, KH domain RNA binding (mouse) | 0.010 | ||
CSF3 | colony stimulating factor 3 (granulocyte) | 0.010 | ||
FOSL1 | FOS-like antigen 1 | 0.010 | Rat | |
UQCRC2 | ubiquinol-cytochrome c reductase core protein II | 0.010 | ||
TGFB3 | transforming growth factor, beta 3 | 0.010 | ||
CXCR1 | chemokine (C-X-C motif) receptor 1 | 0.010 | ||
PICALM | phosphatidylinositol binding clathrin assembly protein | 0.010 | ||
DYNLT3 | dynein, light chain, Tctex-type 3 | 0.010 | ||
TG | thyroglobulin | 0.010 | ||
BECN1 | beclin 1, autophagy related | 0.010 | ||
PTGER4 | prostaglandin E receptor 4 (subtype EP4) | 0.010 | ||
ALPI | alkaline phosphatase, intestinal | 0.010 | ||
CRP | C-reactive protein, pentraxin-related | 0.010 | ||
HABP2 | hyaluronan binding protein 2 | 0.010 | ||
PTPRB | protein tyrosine phosphatase, receptor type, B | 0.010 | ||
LOC100288675 | hypothetical protein LOC100288675 | 0.010 | ||
PLTP | phospholipid transfer protein | 0.010 | ||
DNAH2 | dynein, axonemal, heavy chain 2 | 0.010 | ||
PRKCB | protein kinase C, beta | 0.010 | ||
PADI1 | peptidyl arginine deiminase, type I | 0.010 | ||
CLDN14 | claudin 14 | 0.010 | ||
NOTCH4 | notch 4 | 0.010 | ||
ITGAV | integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51) | 0.010 | ||
STMN1 | stathmin 1 | 0.010 | ||
PPAP2B | phosphatidic acid phosphatase type 2B | 0.010 | ||
TRIM32 | tripartite motif containing 32 | 0.010 | ||
ATP10D | ATPase, class V, type 10D | 0.010 | ||
AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.010 | ||
PDE4C | phosphodiesterase 4C, cAMP-specific | 0.010 | Human | |
NEB | nebulin | 0.010 | ||
ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.010 | ||
MYL9 | myosin, light chain 9, regulatory | 0.010 | ||
NNMT | nicotinamide N-methyltransferase | 0.010 | ||
SOCS2 | suppressor of cytokine signaling 2 | 0.010 | ||
ICOSLG | inducible T-cell co-stimulator ligand | 0.010 | ||
MAP3K1 | mitogen-activated protein kinase kinase kinase 1 | 0.010 | ||
SARDH | sarcosine dehydrogenase | 0.010 | ||
MOG | myelin oligodendrocyte glycoprotein | 0.010 | ||
APOB | apolipoprotein B (including Ag(x) antigen) | 0.010 | ||
ADAMTS1 | ADAM metallopeptidase with thrombospondin type 1 motif, 1 | 0.010 | ||
SCN1B | sodium channel, voltage-gated, type I, beta | 0.010 | ||
E2F1 | E2F transcription factor 1 | 0.010 | ||
AQP2 | aquaporin 2 (collecting duct) | 0.010 | Human | |
BCL6 | B-cell CLL/lymphoma 6 | 0.010 | ||
AHSG | alpha-2-HS-glycoprotein | 0.010 | ||
KLF1 | Kruppel-like factor 1 (erythroid) | 0.010 | ||
GPR116 | G protein-coupled receptor 116 | 0.010 | ||
GRID1 | glutamate receptor, ionotropic, delta 1 | 0.010 |